-
EP4204457
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP4204457
| EP4204457 - BCMA CHIMERIC ANTIGEN RECEPTORS [Right-click to bookmark this link] | Status | Request for examination was made Status updated on 02.06.2023 Database last updated on 20.07.2024 | |
| Former | The international publication has been made Status updated on 05.03.2022 | Most recent event Tooltip | 10.05.2024 | Change - applicant | published on 12.06.2024 [2024/24] | Applicant(s) | For all designated states Regeneron Pharmaceuticals, Inc. 777 Old Saw Mill River Road Tarrytown, NY 10591 / US | [2024/24] |
| Former [2023/27] | For all designated states 2seventy bio, Inc. 60 Binney Street Cambridge, MA 02142 / US | Inventor(s) | 01 /
CONTRASTANO, Shannon Grande Auburndale, Massachusetts 02466 / US | 02 /
KUIPER, Emily G. Arlington, Massachusetts 02474 / US | [2023/27] | Representative(s) | Forresters IP LLP Skygarden Erika-Mann-Straße 11 80636 München / DE | [2023/27] | Application number, filing date | 21862543.2 | 24.08.2021 | [2023/27] | WO2021US47290 | Priority number, date | US202063069784P | 25.08.2020 Original published format: US 202063069784 P | [2023/27] | Filing language | EN | Procedural language | EN | Publication | Type: | A2 Application without search report | No.: | WO2022046730 | Date: | 03.03.2022 | Language: | EN | [2022/09] | Type: | A2 Application without search report | No.: | EP4204457 | Date: | 05.07.2023 | Language: | EN | The application published by WIPO in one of the EPO official languages on 03.03.2022 takes the place of the publication of the European patent application. | [2023/27] | Search report(s) | International search report - published on: | US | 03.03.2022 | Classification | IPC: | C07K16/28 | [2023/27] | CPC: |
C07K16/2878 (EP,IL,KR,US);
A61K39/4631 (EP,IL,KR,US);
A61K35/17 (KR);
A61K39/4611 (EP,IL,KR,US);
A61K39/464417 (EP,IL,KR);
A61P35/00 (KR,US);
C07K14/7051 (EP,IL,KR);
C07K14/70517 (KR);
C07K14/70521 (KR);
C12N15/86 (KR,US);
C12N5/0636 (KR);
A61K2039/5158 (KR);
A61K2239/22 (EP,IL,KR);
A61K2239/28 (EP,IL,KR);
A61K2239/48 (US);
C07K2317/56 (EP,IL);
C07K2317/565 (EP,IL,KR);
C07K2317/622 (EP,IL,KR,US);
C07K2317/73 (EP,IL,KR);
C07K2319/02 (KR);
C07K2319/03 (EP,IL,KR);
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2023/27] | Extension states | BA | 02.03.2023 | ME | 02.03.2023 | Validation states | KH | 02.03.2023 | MA | 02.03.2023 | MD | 02.03.2023 | TN | 02.03.2023 | Title | German: | CHIMÄRE BCMA-ANTIGENREZEPTOREN | [2023/27] | English: | BCMA CHIMERIC ANTIGEN RECEPTORS | [2023/27] | French: | RÉCEPTEURS ANTIGÉNIQUES CHIMÉRIQUES SENSIBLES À BCMA | [2023/27] | Entry into regional phase | 02.03.2023 | National basic fee paid | 02.03.2023 | Search fee paid | 02.03.2023 | Designation fee(s) paid | 02.03.2023 | Examination fee paid | Examination procedure | 02.03.2023 | Examination requested [2023/27] | 03.10.2023 | Amendment by applicant (claims and/or description) | Fees paid | Renewal fee | 15.08.2023 | Renewal fee patent year 03 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | |||